Thomas J. Herzfeld Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-85	Closed	-$1.14K	–	302
2023 Q3	$1.14K	Hold	85	–	–	﹤0.01%	334
2023 Q2	$1.07K	Sell	85 -110	-56%	-$1.28K	﹤0.01%	330
2023 Q1	$2.22K	Buy	+195	New	+$2.1K	﹤0.01%	295
2021 Q4	–	Sell	-120	Closed	-$2K	–	380
2021 Q3	$2K	Sell	120 -110	-48%	-$1.47K	﹤0.01%	336
2021 Q2	$3K	Hold	230	–	–	﹤0.01%	327
2021 Q1	$3K	Buy	+230	New	+$2.95K	﹤0.01%	313

Other funds holding RDY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Thomas J. Herzfeld Advisors's RDY Position: Q4 2023 in Review

Thomas J. Herzfeld Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q4 2023, closing a stake of 85 shares — an estimated $1.14K sold.

Thomas J. Herzfeld Advisors first reported a position in RDY in Q1 2021 and held it in 6 quarters. The position peaked at $3K in Q2 2021. 224 funds tracked by Wall St. Rank hold RDY as of Q4 2023.

Thomas J. Herzfeld Advisors reported no remaining Dr. Reddy's Laboratories position as of Q4 2023 after selling out during the quarter.
Thomas J. Herzfeld Advisors sold 85 Dr. Reddy's Laboratories shares in Q4 2023, an estimated $1.14K.
Thomas J. Herzfeld Advisors first reported a position in Dr. Reddy's Laboratories in Q1 2021 and held it in 6 quarters.
Thomas J. Herzfeld Advisors's Dr. Reddy's Laboratories position peaked at $3K in Q2 2021.
224 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2023.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.